Skip directly to content

Letter Addressing Conflict of Interest Created by J&J Donations of Bedaquiline in India

TAG is one of the signatories on this April 29, 2019 civil society letter that was sent to India’s Ministry of Health and Family Welfare concerning Johnson & Johnson’s ad-hoc donations of the TB drug bedaquiline – a very important new drug in the treatment of MDR-TB.

As the letter states, “The donations of BDQ to India not only create dependence on donations from a single supplier but also stifle the Government’s willingness to promote local production of BDQ by generic manufacturers to ensure affordable, sustainable and predictable supply to the Government program.”

View Download the Letter